Background. Identification of genes that are specifically activated in restenosis lesions after percutaneous transluminal angioplasty represents a necessary step toward molecular manipulation designed to inhibit cellular proliferation responsible for such lesions. Whereas quiescent smooth muscle cells (contractile phenotype) preferentially express smooth muscle myosin, proliferating smooth muscle cells (synthetic phenotype) have been shown to preferentially express nonmuscle myosin in vitro. Accordingly, we analyzed the expression of a recently cloned isoform of human nonmuscle myosin heavy chain (MHC-B) in fresh human restenotic lesions.
Methods and Results. A total of 10 lesions, including four restenosis (three superficial femoral arterial lesions and one saphenous vein bypass lesion) and six primary (four superficial femoral arterial lesions and two coronary arterial lesions) obtained percutaneously by directional atherectomy, were processed for examination by in situ hybridization. In total, 150 tissue sections of restenotic lesions (66 sections), primary lesions (78 sections), and normal internal mammary artery (six sections) were hybridized with the nonmuscle MHC-B probe.
Restenotic lesions showed intense hybridization to the nonmuscle MHC-B cRNA probe, as demonstrated by a clustering of more than 20 grains per cell nucleus in 80% of the cells examined within a high-power field (X250); in contrast, an equivalent degree of hybridization was observed in only 7% of cells within primary lesions (p<0.001). Results of immunocytochemistry using monoclonal antibody to smooth muscle actin indicated that cells demonstrating strong hybridization were smooth muscle in origin.
Conclusions. These findings demonstrate that 1) human vascular tissue obtained by percutaneous directional atherectomy constitutes appropriate biopsy material for gene expression studies at the mRNA level, and 2) nonmuscle MHC-B mRNA is present in greater abundance among restenotic versus primary vascular stenoses. These observations thus provide a rational basis to explore restenotic lesions on a larger scale to identify genes that are activated in these lesions and establish potential targets for future gene 18 .5 mg; range, 5.8-45.1 mg22), the suitability of such specimens for analysis with molecular probes has remained uncertain. Indeed, the use of molecular probes to study these specimens has not been described previously. Accordingly, the current study was designed to investigate 1) the feasibility of using human atherosclerotic material obtained percutaneously by directional atherectomy for molecular analysis at the gene transcriptional level and 2) the expression of an isoform of human nonmuscle MHC in primary versus restenotic vascular lesions using in situ hybridization.
Methods

Study Patients and Atherectomy Procedure
The material analyzed in this study consisted of biopsies of primary and restenotic lesions obtained from patients undergoing directional atherectomy for symptomatic coronary or peripheral vascular disease.
Biopsies In all, 10 lesions were retrieved from 10 patients. In four cases, the lesions were classified as restenosis lesions because they occurred at the site of previous balloon angioplasty; the mean time from angioplasty to atherectomy was 6 months ( Table 1 ). The site of restenosis involved the superficial femoral artery in three patients and a coronary artery bypass graft in one. The six remaining lesions were classified as primary; revascularization of these six lesions had not been attempted previously. These six primary lesions involved the superficial femoral arteries in four patients and the coronary arteries in two. Certain clinical characteristics of these 10 patients are summarized in Table 1 .
Tissue Preparation for In Situ Hybridization
Each atherectomy specimen was removed expeditiously from the atherectomy collection chamber and immersed in ice-cold 4% paraformaldehyde (Fisher Scientific, Fair Lawn, N.J.) within 2 minutes of retrieval to minimize RNA degradation. Paraformaldehyde immersion was continued for 2 hours, after which the specimens were placed in 30% sucrose/ phosphate buffered saline (PBS) overnight at 4°C to decrease freezing artifacts. Specimens were then embedded in O.C.T. compound (Miles Scientific, Elkhart, Ind.) and snap-frozen in liquid nitrogen. Multiple frozen sections 7 ,um thick were then cut from each specimen on a cryostat (Miles), placed on the lower half of specially prepared gelatin-chromic alum-coated glass slides, and baked in a 40°C oven overnight to increase the adhesiveness of the frozen sections to the glass slides.
Tissue sections were next rehydrated in PBS for two 5-minute washes, followed by two 5-minute washes in 0.1 mol/l glycine/PBS (Fisher) and one 15-minute wash in 0.3% Triton X-100/PBS (Fisher) to break the lipid bilayer. This was followed by two 3-minute washes in PBS. Membrane protein digestion was then carried out with Proteinase K (Boehringer-Mannheim, FRG) ( weeks of exposure, slides were developed using D-19 (Eastman Kodak), 2% acetic acid, and Kodak Fixer. Counterstaining was done with hematoxylin and eosin. In all, 150 tissue sections were hybridized during three in situ hybridization experiments. The first hybridization study was performed 1) to evaluate the optimal number of sections per specimen needed to obtain reproducible results (to take account of sections with a surface area of 1-2 mm2 lost during the washing procedure) and 2) to determine the exposure time that would optimize signalto-noise ratio with the nonmuscle MHC-B probes. This first in situ analysis involved 84 sections: 42 of a restenotic lesion and 42 of a primary lesion, each of which was hybridized to the antisense and sense nonmuscle MHC-B probes. Sections of each type of lesion (21 restenosis and 21 primary) were developed early (2 weeks' exposure) and the same number of each lesion type were developed late (4 weeks). The second in situ hybridization analysis involved 42 different sections of the peripheral lesions, including 18 sections of restenotic lesions, and 24 sections of primary lesions. The third in situ analysis involved 24 specimens obtained from the coronary arteries, coronary venous bypass graft, and internal mammary artery.
Probe Preparation
A recently cloned cDNA coding for the human nonmuscle MHC-B gene, subcloned into the pGEM3Zf(-) vector (Promega Corp., Madison, Wis.), was used to generate antisense and sense RNA transcripts labeled with 35S[UTP] (specific activity: 1,300 Ci/mmol) (NEN Research Products, Boston, Mass.). SP6 and T7 polymerases were used for preparation of the antisense and sense probes, respectively. To examine the extent of cross-hybridization of the nonmuscle myosin probe to smooth muscle myosin, sections of normal human internal mammary artery freshly harvested at the time of coronary bypass surgery were hybridized with the nonmuscle MHC-B probes. This control tissue was prepared in a manner identical to that described for the vascular lesions above. To control for the specificity of the antisense cRNA probe, parallel in situ hybridization procedures were performed with the sense cRNA probe.
Finally, hybridization specificity was ensured with RNAse treatment after the hybridization reaction.
Immunocytochemistry
To confirm that those cells showing strong hybridization were smooth muscle cells, 7-,um sections adjacent to those used for in situ hybridization were examined by immunoperoxidase staining technique. Tissues were prepared as described for the in situ hybridization procedure. A monoclonal antibody directed against a-actin smooth muscle (Sigma) was used as the primary antibody. The sections were then sequentially exposed to the anti-mouse immunoglobulin, the peroxidase-labeled mouse IgG, and finally the substrate chromogen (Signet Laboratories, Dedham, Mass.). The tissues were then counterstained with hematoxylin and eosin.
Tissue Section Analysis
Results of the in situ hybridization were analyzed by hand counting of silver grains overlying cell nuclei. We used the relation of silver grains to cell nucleus to ascertain a cell hybridization signal strength because membrane borders of individual cells in frozen atherosclerotic plaque are not readily identifiable. Strong hybridization was said to be present when a cell nucleus showed a clustering of more than 20 silver grains overlying it. The numbers of cell nuclei showing strong hybridization were counted for all the fields and presented as a percentage of the total number of cell nuclei counted. All 150 sections were qualitatively examined, and 100 fields were quantitatively analyzed at x 250 magnification. For each specimen, five fields were randomly chosen on a tissue section exposed to the antisense probe. Silver grains were hand counted on two different sections per specimen; thus, in total, 10 
Results
In total, 150 tissue sections of restenotic lesions (66 sections), primary lesions (78 sections), and normal human internal mammary artery (six sections) were hybridized with the nonmuscle MHC-B probes. The first in situ hybridization study demonstrated that signal-to-noise ratio was optimal on sections exposed for a period of 2 weeks. Accordingly, exposure time for subsequent in situ hybridization with nonmuscle MHC-B mRNA was limited to that time period. The first in situ hybridization study also demonstrated that tissue loss resulting from multiple washes was surprisingly limited despite the small area the section occupied on the coated glass slides; during subse- quent analyses, therefore, we limited the number of sections per specimen to be hybridized to four with the antisense probe and two with the sense probe. In total, 100 fields were analyzed quantitatively for cellularity and hybridization intensity ( Table 2) .
Light Microscopy
Qualitative analysis of the hematoxylin-eosinstained sections revealed that the restenosis lesions appeared hypercellular and loosely collagenous; in contrast, the primary lesions were generally more fibrous and less cellular. Semiquantitative analysis disclosed 8.9+0.5 cell nuclei per field for the restenotic lesions versus 5.5+±0.4 cell nuclei per field for the primary lesions (p<0.001) (Figure 1 ). Irregular calcific deposits were observed in the primary lesions, whereas no calcific deposits were seen in the restenosis specimens.
In Situ Hybridization
Samples of negative and positive hybridization results at the single cell level are illustrated in Figure  2 . A cell nucleus without significant hybridization signal is shown in Figure 2a ; in contrast, Figure 2b illustrates a strong signal (clustering of >20 silver grains per cell nucleus). Representative sections from the restenotic lesions are shown in Figure 3 . The section shown in Figure 3a was taken from a peripheral restenosis lesion; positive hybridization of most of the cells included in the field to the antisense cRNA probe for the human nonmuscle MHC-B mRNA is indicated by clustering of silver grains over 10- p<0.OO1 Similarly diminished hybridization was observed in the primary coronary lesions (Figure 5b ). Semiquantitative analysis (Figure 4) showed that only 7% of cells from primary lesions fulfilled criteria for strong hybridization defined above (versus 80% in restenosis lesions, p<0.001).
To demonstrate that there was no extensive crosshybridization of the antisense nonmuscle MHC-B probe with vascular smooth muscle MHC mRNA, sections of normal internal mammary artery were hybridized with the nonmuscle MHC-B probes (Figure 6 ). Intense hybridization of the antisense probe, as found in restenosis lesions, was not observed in any of these sections.
Immunocytochemistry
Representative results of slides stained for immunocytochemistry are illustrated in Figure 7 . Cells demonstrating strong hybridization with the nonmuscle MHC-B probes consistently demonstrated positive immunoperoxidase staining after exposure to the a-actin smooth muscle monoclonal antibody (Figure  7a ), indicating the identity of these cells to be of smooth muscle origin. The intensity of staining found in cells from the atherectomy specimens was weaker than that observed in control tissues (normal human internal mammary artery, Figure 7b ), presumably because of growth-related transition of actin isoform expression in vascular smooth muscle cells.26 Discussion Directional atherectomy is unique among devices currently approved for percutaneous revascularization in that biopsy specimens of atherosclerotic plaque can be obtained sufficiently intact to be studied by light microscopy. [20] [21] [22] In situ hybridization represents a contemporary light microscopic technique that permits morphological localization of specific DNA or RNA sequences at the single cell level.2728 Although a powerful method for detection of mRNA, it is limited by the fact that such studies must be done on fresh tissues to minimize RNA digestion by endogenous RNAse. Necropsy specimens are thus much less suitable for such analysis; furthermore, opportunities to obtain tissue specimens from restenosis lesions at necropsy are relatively infrequent. While more frequent, the opportunity to obtain tissue specimens at the time of bypass surgery is a technically inconvenient opportunity for tissue retrieval. Therefore, we investigated the possibility that directional atherectomy might prove to be a useful means by which to study gene activation in atherosclerosis.
In situ hybridization of human atherosclerotic plaque was pioneered by Wilcox et a129 to investigate expression of specific genes in specimens freshly harvested from human carotid arterial stenoses at the time of surgical endarterectomy. Because in situ hybridization of specimens obtained by directional atherectomy may be used to localize expression of mRNA at the single cell level, it is well suited to exploit the biopsy potential of directional atherectomy, which preserves the histoarchitecture of the retrieved specimen intact.30 This is in direct contrast to atherosclerotic tissue removed by alternative atherectomy techniques. Furthermore, repeated in situ hybridization (up to 10 studies, depending on number of sections per study) can be performed on the same specimen using different molecular probes.
The current study represents the first report of gene expression in human restenotic lesions analyzed by in situ hybridization. These preliminary findings indicate that at least one isoform of nonmuscle MHC is expressed in abundant fashion by a majority of cells within these lesions. Moreover, the restenosis lesion appears to contain more human nonmuscle MHC-B mRNA per cell than primary lesions. These findings are consistent with the notion that actively prolif- (hematoxylin -eosin counterstain). Although peroxidase staining is seen over most cells in the restenosis lesion, the stain intensity is lower than that observed in the media of the control intemal mammary artery.
Although this study focused on gene expression at the mRNA level, inferential evidence suggests that these findings may in fact reflect gene expression at the protein level. A growth-related transition between smooth muscle and nonmuscle myosin isoforms has previously been demonstrated in vitro at the protein level. Rovner and coworkers,13 using polyclonal antibodies, showed that proliferating cells synthesize almost exclusively nonmuscle myosin, whereas quiescent cells produce smooth muscle and nonmuscle myosin. Recently, this growth-related transition between myosin isoforms has also been observed in an animal model. Using hypercholesterolemic rabbits, Kuro-o et a115 showed that the expression of a rabbit nonmuscle MHC gene (embryonic vascular smooth muscle MHC isoform [SMemb]) was induced in smooth muscle cells that constituted the exuberantly proliferative, experimentally induced rabbit atheroma. We speculate that the SMemb MHC isoform is in fact the rabbit homolog of the human nonmuscle MHC-B isoform described in this report.
We used smooth muscle a-actin monoclonals to identify smooth muscle cells in these lesions as has been done by others. 15, 20, 29, 3032 The positive staining for smooth muscle a-actin observed in sections from restenotic lesions in the present study supports the notion that most of the cells found in such lesions are of smooth muscle origin. However, the intensity of staining for a-actin was somewhat weaker in the restenotic sections versus sections of normal human internal mammary artery. This observation might also reflect a growth-related transition seen in vitro between smooth muscle actin isoforms. 26 The These results constitute strong evidence for the essential role of nonmuscle myosin in cytokinesis.
Identification of the nonmuscle MHC-B gene overexpression in restenotic vascular lesions outlined in this report comes at a time when interest in gene therapy is increasing. 34 In view of the fact that pharmacological attempts to manage restenosis have thus far proved unsuccessful,16 a genetic approach represents a timely consideration. Recent reports have documented successful seeding of intravascular stents with genetically engineered endothelial cells35 and recombinant gene delivery to specific sites in the arterial wall of an experimental animal model mediated by retroviral vector or cationic lipid vesicles. 32 The approach described in the present report may be useful to identify molecular targets for future gene therapy designed to interfere with smooth muscle cell proliferation. Further exploratory studies to examine the exact function of nonmuscle myosin in proliferating vascular smooth muscle cells will determine the extent to which these genes constitute appropriate targets.
